NPC's John O'Brien to Speak at Asembia's AXS26 Summit
Join NPC's John M. O'Brien, PharmD, MPH during Asembia's Specialty Pharmacy Summit in Las Vegas.
Look for NPC President and CEO John M. O'Brien, PharmD, MPH at the Asembia Specialty Pharmacy Summit in Las Vegas.
Drug Pricing in Flux: Navigating the Policy Crossroads of 2026
Wednesday, April 29, 2026 | 1:00 PM – 1:40 PM PT
As U.S. drug pricing policy evolves at a breakneck pace, from Inflation Reduction Act negotiations to the sweeping reforms in the One Big Beautiful Bill Act, manufacturers face a moving target when preparing for launch and access. This session will unpack what’s known, what’s still in play, and how companies can strategically anticipate the ripple effects of policy shifts without losing momentum on pricing and market access. Moreover, global pricing and launch sequencing strategy considerations are becoming apparent. Drawing on real-world expertise in launch sequencing, contracting strategy, and payer engagement, our panel will spotlight how today’s uncertainty can actually be turned into tomorrow’s advantage. Expect a frank and forward-looking discussion that pulls together leading experts in pricing and access strategy to separate the signal from the noise.
Panel:
- Greg Gregory, EVP, Managing Partner, Access Consulting, Precision AQ
- Jeff Berkowitz, CEO, Real Endpoints
- Lisa Edwards, Senior Director Access Experience Team, Precision AQ
- John M. O'Brien, President and CEO, National Pharmaceutical Council
Learn More
For agenda, speaker, and registration information, visit the Asembia 2026 Summit website.